Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Dec 16, 2022; 14(12): 769-776
Published online Dec 16, 2022. doi: 10.4253/wjge.v14.i12.769
Published online Dec 16, 2022. doi: 10.4253/wjge.v14.i12.769
Our initial single port robotic cholecystectomy experience: A feasible and safe option for benign gallbladder diseases
Huseyin Kemal Rasa, Ayhan Erdemir, Department of General Surgery, Anadolu Medical Center Hospital, Kocaeli 41400, Turkey
Author contributions: Rasa HK contributed to conceptualization of the study, methodology, writing, review and editing of the manuscript, and project administration; Erdemir A contributed to conceptualization of the study, methodology, formal analysis of the data, investigation into the literature and writing of the original draft of the manuscript; both authors read and approved the final manuscript.
Institutional review board statement: The study was conducted following the Declaration of Helsinki (as revised in 2013) and was approved by Anadolu Medical Center Hospital review board and ethics committee (ASM-EK-22/186).
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest.
Data sharing statement: The datasets analyzed during the current study are available in the hospital’s “electronic patient records” and from the corresponding author on reasonable request.
STROBE statement: The authors have read the STROBE Statement—a checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—a checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Huseyin Kemal Rasa, MD, Attending Doctor, Department of General Surgery, Anadolu Medical Center Hospital, Cumhuriyet Mahallesi 2255 Sokak No 3 Gebze, Kocaeli 41400, Turkey. kemrasa@gmail.com
Received: September 22, 2022
Peer-review started: September 22, 2022
First decision: October 20, 2022
Revised: November 25, 2022
Accepted: December 1, 2022
Article in press: December 1, 2022
Published online: December 16, 2022
Peer-review started: September 22, 2022
First decision: October 20, 2022
Revised: November 25, 2022
Accepted: December 1, 2022
Article in press: December 1, 2022
Published online: December 16, 2022
Core Tip
Core Tip: We retrospectively analyzed 40 consecutive patients with cholelithiasis who underwent single-port robotic cholecystectomy from 2013 to 2021. We believe that the learning curve for single-port robotic cholecystectomy surgery is not long, and after a particular experience, the operation times are significantly shortened. Our data suggest that it is a safe surgery with acceptable intraoperative blood loss, no conversion, and no bile duct injury or postoperative bile leak. Our data also support more liberal graft use during the fascia closure. Single-port robotic cholecystectomy is a feasible and safe option that should be considered when treating patients with gallstones.